Quanterix (QTRX)
(Delayed Data from NSDQ)
$11.76 USD
+0.70 (6.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.74 -0.02 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.76 USD
+0.70 (6.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.74 -0.02 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Zacks News
Here's Why Investors Should Retain STERIS (STE) Stock for Now
by Zacks Equity Research
STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism.
Here's Why You Should Buy Align Technology (ALGN) Stock Now
by Zacks Equity Research
The rapid expansion of Align Technology's (ALGN) business in international markets remains a key growth driver.
Henry Schein (HSIC) Gains From Strong Global Network Amid FX Woes
by Zacks Equity Research
Henry Schein's (HSIC) dental software business is progressing well despite a challenging business environment.
Terumo's (TRUMY) MicroVention Enters Transradial Access Space
by Zacks Equity Research
The SOFIA EX 5F Catheter by Terumo's (TRUMY) MicroVention boasts a new design to enhance trackability.
Charles River (CRL) Opens a RightSource Lab in Stevenage
by Zacks Equity Research
Charles River's (CRL) new RightSource facility is likely to provide services to the Stevenage advanced therapy biocluster.
ResMed (RMD) Gains From Mask Sales Amid Macro Headwinds
by Zacks Equity Research
ResMed's (RMD) respiratory care business continues to drive growth, courtesy of the adoption of bilevel and other non-invasive ventilator solutions worldwide.
Boston Scientific (BSX) Set to Acquire Relievant Medsystems
by Zacks Equity Research
Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.
Align (ALGN) Gains From Growing Invisalign Volume, Innovation
by Zacks Equity Research
Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.
Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM
by Zacks Equity Research
Medtronic's (MDT) next-generation sensor Simplera receives CE Mark approval.
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
by Zacks Equity Research
Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.
Abbott (ABT) to Commercialize Biosimilars in Emerging Markets
by Zacks Equity Research
Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.
Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing
by Zacks Equity Research
According to Orthofix (OFIX), with the launch of the Galaxy Fixation Gemini system surgeons now have efficient solutions for lower extremity trauma scenarios where time is an important factor.
Hologic (HOLX) Gains From New Launches as Macro Concerns Rise
by Zacks Equity Research
Hologic (HOLX) has been making impressive progress in its Breast Health arm, leveraging its strategic expansion efforts to diversify business across the patient continuum of care.
Abbott (ABT) Broadens Electrophysiology Footprint With TactiFlex
by Zacks Equity Research
The successful deployment of Abbott's (ABT) TactiFlex Ablation Catheter, Sensor Enabled in Canada broadens the company's global footprint in the electrophysiology space.
Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up
by Zacks Equity Research
Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina.
Phibro (PAHC) Sales Impacted by Macro Concerns, FX Headwind
by Zacks Equity Research
The COVID-19 pandemic has adversely affected the international economic conditions and financial markets, leading to an economic downturn in many countries, in which Phibro (PAHC) operates.
Myriad Genetics' (MYGN) New Deal to Use MRD Testing Platform
by Zacks Equity Research
Myriad Genetics (MYGN) announces a collaboration with Memorial Sloan Kettering Cancer Center to study the use of MRD testing in breast cancer.
Here's Why You Should Retain National Vision (EYE) Stock Now
by Zacks Equity Research
Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and stable liquidity.
Teleflex (TFX) Rides on Urolift Prospects Amid Cost Pressures
by Zacks Equity Research
With respect to Teleflex's (TFX) market development objectives for UroLift, the company witnesses growth for UroLift in the hospital setting.
Teleflex (TFX) Picked for Vizient Innovative Technology Exchange
by Zacks Equity Research
Teleflex (TFX) gets selected to exhibit Arrow VPS Rhythm DLX Device and Arrow PICCs preloaded with the NaviCurve Stylet at the Vizient Innovative Technology Exchange.
Alcon (ALC) Gains From Innovation & International Expansion
by Zacks Equity Research
Alcon's (ALC) Surgical business continues to gain from diverse portfolio and incremental innovation.
Teleflex (TFX) New Survey Highlights BPH Impact Life Quality
by Zacks Equity Research
Teleflex's (TFX) survey results highlight how crucial it is for men to consult a urologist if they have strange or troublesome urine symptoms.
Charles River (CRL) Announces Partnership With Related Sciences
by Zacks Equity Research
Charles River's (CRL) new collaboration is likely to leverage the AI-powered drug discovery and development platform, Logica.
Here's Why You Should Retain Insulet (PODD) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.
Quest Diagnostics (DGX) to Aid Health Equity With New Pact
by Zacks Equity Research
Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.